Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Health OTC Drugs Market Intelligence

Generics Players Dominating New OTC Launches In Germany

  • News

Executive Summary

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.

Table

View full table

Topics

Related Companies

Tags:
Health OTC Drugs Market Intelligence
Latest Headlines

Biocon And Biomm Team Up In Brazil On Ozempic Rival – With Potential Near-Term Launch

Amneal Launches Ready-To-Use Pemetrexed And OTC Naloxone

…And Amgen Makes Three: Another Ustekinumab Biosimilar Gets Go-Ahead In EU

No Takers For Biogen’s Biosimilars Business?

See All
UsernamePublicRestriction

Register

RS149096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By